Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black acquired 43,492 shares of the firm’s stock in a transaction on Thursday, May 18th. The shares were purchased at an average cost of $2.22 per share, for a total transaction of $96,552.24. Following the completion of the purchase, the chief financial officer now directly […]
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black bought 43,492 shares of the firm’s stock in a transaction dated Thursday, May 18th. The shares were bought at an average price of $2.22 per share, with a total value of $96,552.24. Following the completion of the transaction, the chief financial officer now directly […]
Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period.
Standard BioTools (NASDAQ:LAB – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Earnings & Valuation This table compares Standard BioTools and […]
Susquehanna International Group LLP raised its position in shares of Standard BioTools Inc. (NASDAQ:LAB – Get Rating) by 189.5% in the fourth quarter, Holdings Channel reports. The fund owned 43,137 shares of the company’s stock after buying an additional 28,237 shares during the quarter. Susquehanna International Group LLP’s holdings in Standard BioTools were worth $50,000 […]